Geneva: The World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering Committee on Saturday, to discontinue the trials of hydroxychloroquine (HCQ) and lopinavir/ritonavir arms.
According to a press release, citing little or no reduction in the mortality rate of the hospitalised COVID-19 patients, WHO reportedly said, the decision was in light of the evidence from the Solidarity Trial’s interim results.
“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized Covid-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect,” Xinhua reported WHO’s release.
The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for patients already admitted to hospitals.
Lucknow: Three terrorists accused of lobbing a grenade at a police post in Punjab’s Gurdaspur…
Malkangiri: If things go as per plan, flight services between Odisha’s Malkangiri town and Visakhapatnam…
Bhubaneswar: Unidentified miscreants allegedly attacked a man and kidnapped his female friend in Maitri Vihar…
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
This website uses cookies.